A detailed history of Susquehanna International Group, LLP transactions in Spero Therapeutics, Inc. stock. As of the latest transaction made, Susquehanna International Group, LLP holds 44,219 shares of SPRO stock, worth $52,178. This represents 0.0% of its overall portfolio holdings.

Number of Shares
44,219
Previous 23,073 91.65%
Holding current value
$52,178
Previous $29,000 103.45%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$1.19 - $1.5 $25,163 - $31,719
21,146 Added 91.65%
44,219 $59,000
Q2 2024

Aug 15, 2024

BUY
$1.27 - $1.8 $29,302 - $41,531
23,073 New
23,073 $29,000
Q4 2023

Feb 14, 2024

SELL
$1.0 - $1.47 $2,097 - $3,082
-2,097 Reduced 10.39%
18,086 $26,000
Q3 2023

Nov 14, 2023

SELL
$1.2 - $1.63 $29,011 - $39,406
-24,176 Reduced 54.5%
20,183 $24,000
Q2 2023

Aug 11, 2023

BUY
$1.42 - $1.95 $25,297 - $34,739
17,815 Added 67.11%
44,359 $64,000
Q1 2023

May 16, 2023

SELL
$1.35 - $2.0 $32,541 - $48,210
-24,105 Reduced 47.59%
26,544 $38,000
Q4 2022

Feb 14, 2023

SELL
$1.55 - $2.12 $28,887 - $39,510
-18,637 Reduced 26.9%
50,649 $87,000
Q3 2022

Nov 14, 2022

BUY
$0.68 - $2.2 $10,295 - $33,310
15,141 Added 27.96%
69,286 $139,000
Q2 2022

Aug 15, 2022

SELL
$0.74 - $7.44 $9,574 - $96,266
-12,939 Reduced 19.29%
54,145 $40,000
Q1 2022

May 16, 2022

SELL
$7.87 - $15.15 $63,739 - $122,699
-8,099 Reduced 10.77%
67,084 $584,000
Q4 2021

Feb 14, 2022

BUY
$13.09 - $18.77 $463,844 - $665,114
35,435 Added 89.15%
75,183 $1.2 Million
Q3 2021

Nov 15, 2021

SELL
$13.03 - $19.51 $22,281 - $33,362
-1,710 Reduced 4.12%
39,748 $732,000
Q2 2021

Aug 11, 2021

SELL
$12.22 - $15.79 $338,799 - $437,777
-27,725 Reduced 40.07%
41,458 $579,000
Q1 2021

May 17, 2021

SELL
$13.23 - $21.48 $64,760 - $105,144
-4,895 Reduced 6.61%
69,183 $1.02 Million
Q4 2020

Feb 16, 2021

BUY
$11.65 - $22.07 $194,205 - $367,906
16,670 Added 29.04%
74,078 $1.44 Million
Q3 2020

Nov 16, 2020

BUY
$8.96 - $14.12 $153,735 - $242,270
17,158 Added 42.63%
57,408 $641,000
Q2 2020

Aug 14, 2020

BUY
$7.27 - $14.18 $292,617 - $570,745
40,250 New
40,250 $545,000
Q4 2019

Feb 14, 2020

SELL
$9.46 - $12.16 $104,655 - $134,526
-11,063 Closed
0 $0
Q3 2019

Nov 14, 2019

BUY
$9.01 - $12.55 $99,677 - $138,840
11,063 New
11,063 $117,000

Others Institutions Holding SPRO

About Spero Therapeutics, Inc.


  • Ticker SPRO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 35,067,500
  • Market Cap $41.4M
  • Description
  • Spero Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on identifying, developing, and commercializing treatments for multi-drug resistant (MDR) bacterial infections and rare diseases in the United States. The company's product candidates include tebipenem pivoxil hydrobromide (HBr), an oral carbapenem-class antibiotic to ...
More about SPRO
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.